X4 Pharmaceuticals, Inc. (XFOR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for X4 Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2.14x | -3.94x | -1.47x | -0.67x | -0.66x | -2.08x |
| P/B Ratio | 0.91x | 6.66x | 2.92x | 0.85x | 0.92x | 1.77x |
| P/S Ratio | 4.82x | 57.69x | 0.00x | 0.00x | 0.00x | 43.03x |
| Profitability | ||||||
| Gross Margin | 82.2% | 68.8% | 0.0% | 0.0% | 0.0% | 59.0% |
| Operating Margin | -247.4% | -1423.6% | 0.0% | 0.0% | 0.0% | -1995.8% |
| Net Margin | -225.6% | -1464.6% | 0.0% | 0.0% | 0.0% | -2071.0% |
| EBITDA Margin | -243.8% | -1078.5% | 0.0% | 0.0% | 0.0% | -1954.8% |
| Liquidity | ||||||
| Current Ratio | 10.16x | 3.41x | 5.34x | 5.76x | 6.27x | 6.97x |
| Quick Ratio | 9.98x | 3.33x | 5.34x | 5.76x | 6.27x | 6.97x |
| Leverage | ||||||
| Debt/Equity | 0.41x | 3.53x | 1.14x | 0.52x | 0.62x | 0.53x |
YoY = year-over-year change. Source: FMP..